Home Compare NOVO-B.CO vs ORCL
Stock Comparison · Structural lead, mixed market

Novo Nordisk A/S vs Oracle: Which Stock Looks Stronger in 2026?

Novo Nordisk A/S holds the cleaner structural position, with the lead spread across profitability and valuation. Oracle does not offset that deficit through any equally strong structural edge elsewhere. The market setup is currently leaning toward Oracle, which does not confirm the structural lead. That leaves a split case: the structural lead stays with Novo Nordisk A/S, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (NOVO-B.CO: STOXX 600, ORCL: Russell 1000).

Updated 2026-05-17

This is not just a one-metric split: both profitability and valuation materially support the lead. Novo Nordisk A/S leads by 35 points on the overall comparison score.

Trajectory Similarity
0.66
Moderately similar
Peer-set rank: #7
within Novo Nordisk A/S's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The match is driven mainly by investment intensity and margin trend.

Similarity drivers
investment intensitymargin trend
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
NOVO-B.CO
Novo Nordisk A/S
77
Peer-Score
Signal qualitylow
Peer basis: STOXX 600
vs
ORCL
Oracle Corporation
42
Peer-Score
Signal qualitylow
Peer basis: Russell 1000

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: NOVO-B.CO vs ORCL Profitability 91 21 Stability 34 31 Valuation 88 53 Growth 80 71 NOVO-B.CO ORCL
Gap Ranking
#1 Profitability +70
#2 Valuation +35
#3 Growth +9
#4 Stability +3
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for NOVO-B.CO and ORCL Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer NOVO-B.COORCL Relative valuation Structural strength

Novo Nordisk A/S looks stronger both structurally and on relative valuation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where NOVO-B.CO and ORCL each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY NOVO-B.CO Lower · below norm 0th 50th 100th 72 pct gap ORCL Elevated · above norm 0th 50th 100th 16th 88th
Today NOVO-B.CO sits in the lower portion of its own 5-year history (16th percentile), while ORCL sits higher in its own history (88th). Within each stock's own 5-year context, NOVO-B.CO is at a historically more favourable entry position than ORCL. This reflects entry timing, not which company is structurally stronger — peer-relative analysis is a separate question addressed above.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Profitability
Novo Nordisk A/S ranks near the top of the group on profitability; Oracle Corporation sits in the weaker half.
Valuation
On valuation, the edge is clear — both rank well, but Novo Nordisk A/S sits noticeably higher.
Profitability — Dominant Gap
NOVO-B.CO
91
ORCL
21
Gap+70in favour of NOVO-B.CO

The profitability lead is mainly driven by a 29-point operating margin advantage.

What keeps the gap from being one-sided

The market setup is mixed for both, so the structural comparison carries most of the weight here.

What this means for the comparison

The lead is built on both profitability and valuation, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the NOVO-B.CO vs ORCL comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-driven comparisons

Explore how NOVO-B.CO and ORCL each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.